I N T R O D U C T I O N
Peritoneal dialysis (PD) is an accepted treatment option for end-stage renal disease patients. However, long-term PD is limited by structural and functional changes in the peritoneal membrane and eventually a loss of ultrafiltration induced by PD fluids (PDF) [1] . It has been shown that PDF contain not only high glucose concentrations, but also, as a direct consequence of heat-sterilization, high concentrations of glucose degradation products (GDPs). This heterogeneous group of small-molecular-weight carbonyls includes 5-hydroxymethylfuraldehyde and 3,4-dideoxyglucosone-3-ene, as well as the reactive and potent glycating agents, 3-deoxyglucosone (3-DG), glyoxal (Gx) and methylglyoxal (MG) [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] , collectively referred to as dicarbonyls [12] . GDP exhibits a facile reactivity with various biomolecules, including proteins, DNA and phospholipids, generating stable products at the end of a series of reactions, which have been shown to contribute to the pathogenesis of vascular diseases such as atherosclerosis and diabetes. Recent in vitro studies have demonstrated toxicity of GDP towards human peritoneal mesothelial cells [13, 14] , which have been confirmed in vivo [15] [16] [17] [18] . Existing basic and clinical research in long-term PD has mainly dealt with GDPderived toxicity and the development of therapeutic strategies to reduce the cellular burden of GDP [19, 20] . Currently, there are few data regarding the potential role of detoxification systems of GDP in PD.
Previously studies have shown that MG is a major biologically active component of GDP in PD [21] . MG reacts with proteins, primarily with arginine residues, to form the advanced glycation endproduct (AGE), MG-derived hydroimidazolone isomer 1 (MG-H1) [22] . The accumulation of MG-H1 and other MG-derived AGE on proteins has been linked to the development and progression of vascular diseases such as atherosclerosis, as well diabetic complications, such as neuropathy [23] . The glyoxalase system, which consists of glyoxalase 1 (Glo1) and glyoxalase 2 (Glo2) and the cofactor, reduced glutathione (GSH), is the major route of detoxification of MG and Gx [24] . In vitro, it has been shown that depletion of GSH and NAPDH by increased production of reactive oxygen species (ROS) can lead to decreased in situ activity of Glo1, and a subsequent increase in MG and MG-derived AGE [25] . In vitro, it has been shown that Glo1 activity is reduced with age and was associated with increased modification of mitochondrial proteins [26, 27] , and that in diabetes, reduced Glo1 activity in the sciatic nerve leads to increased susceptibly to modification of sodium-voltaged channel, Na v 1.8 and increased neuronal excitability [23] . Furthermore, age-dependent decrease in Glo1 transcription, expression and activity were associated with delayed wound healing [28] and knockdown of Glo1 mimics diabetic nephropathy in non-diabetic mice [29] .
Within the context of PD, it has been shown in vitro that treatment of PDF with Glo1, in combination with either GSH or aminoguanidine, a scavenger of dicarbonyls, can substantially reduce the concentration of dicarbonyls in PDF [30, 31] .
In this study, the role of Glo1 in modulating dicarbonylinduced peritoneal damage by PDF was investigated in Glo1 heterozygous-deficient (Glo1 −/+ ) mice.
M AT E R I A L S A N D M E T H O D S

Animals and experimental design
Glo1
−/+ mice are viable and display normal reproductive function [32] . All strains were backcrossed on the C57BL/6 background >10 times and C57BL/6-mice (Charles River, Boston, MA, USA) served as controls for all transgenic mice. There were no significant differences with respect to age, body weight, blood pressure and haematocrit values between Glo1 −/+ and wild-type (WT) mice. Mice were housed individually with a 12-h/12-h light/dark cycle and free access to food and water. All procedures in this study were approved by the Animal Care and Use Committees at the Regierungspräsidium Tübingen and Karlsruhe, Germany.
All experiments were performed in 12-week-old female mice (45 WT mice and 45 Glo1 −/+ mice). For the evaluation of baseline characteristics, five WT plus five Glo1 −/+ mice were anaesthetized and perfusion was performed via the left ventricle. Visceral peritoneal tissue was resected from the root of the mesentery and fresh frozen.
For the PD experiment, mice were randomly allocated to four groups each, as shown in Table 1 . Twice daily, the animals received an intraperitoneal injection of 1 mL of the respective PDF at 37°C under sterile conditions. The composition of the PDF is given in Table 2 . One group of mice remained untreated to obtain baseline histologic and molecular data (C). In a second group, the mice were sham injected without instilling solution as a control for intraperitoneal puncture (IP) trauma. Particular care was taken to avoid artificial injury by thermal trauma (fluids were injected at body temperature) and/or contamination of the injected fluids by bacteria or lipopolysaccharides. After 12 weeks of treatment, the experiment was terminated.
Preparation of peritoneal tissue
Mice were anaesthetized and perfusion was performed via the left ventricle, and visceral peritoneal tissue was resected from the root of the mesentery. For the morphological and immunohistochemical analysis, visceral peritoneal tissue samples were fixed in 6% PFA ( pH 7.6), embedded in paraffin and cut into 4 μm thick tissue sections.
Histological and immunohistochemical stainings and analysis
Tissue sections were deparaffinized, rehydrated and incubated in Tris-buffered saline (TBS). For histology, sections were stained with haematoxylin & eosin, periodic acid Schiff (PAS) reagent. For immunohistochemistry the following antibodies were used: anti-MG-AGE (1:50), anti-carboxymethyllysine (CML) (1:50) (BioLogo, Kronshagen, Germany), antitransforming growth factor-β1 (TGF-β1) (1:100), anti-vascular endothelial growth factor (VEGF) (1:100), anti-vimentin (1:25), anti-receptor for AGE (RAGE) (1:50) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and anti-interleukin 6 (IL-6) (1:250) (BioTrend, Köln, Germany). The sections were incubated with the primary antibody overnight at 4°C and thereafter stained with the secondary antibody, alkaline-phosphataseconjugated streptavidin, fast red, and peroxidase-conjugated histofine simple stain, diaminobenzidine. Replacement of the primary antibodies with TBS served as a negative control. Semiquantitative analysis of MG-AGE, CML, RAGE, TGF-β1, VEGF, vimentin and IL-6 was carried out by two blinded observers using a previously described [20, 33] scoring system that comprises a qualitative score of 0-3 (intensity of the staining: 0 = no staining, 1 = low intensity, 2 = medium intensity, 3 = high intensity) and a quantitative score of 0-4 (0 = normal, 1 = 1-25% of tissue affected, 2 = 26-50% affected, 3 = 51-75% affected; 4 = 76-100% affected). The two scores were multiplied, with a maximum possible score of 12; 20 areas per cross-section were analysed. The maximal thickness of the submesothelial compact zone was measured in sections oriented perpendicular to the serosal surface. Vessel number (using PAS staining) per area was counted on a 121-point grid (Leitz, Wetzlar, Germany). Images were taken using a Nikon DS-Qi1Mc quantitative black and white charge-coupled device camera attached to a Nikon Eclipse 80i upright microscope (Nikon, Düsseldorf, Germany).
Clinical parameters
Haemoglobin, urea, sodium, potassium, glucose and creatinine were measured with autoanalysers (ADVIA 2400 and ADVIA 2120, Siemens, Eschborn, Germany).
Peritoneal equilibration test
A modified mini-peritoneal equilibration test (PET) was performed as previously described [34] . Briefly 2 mL of PDF were injected. After 1 h, the intra-abdominal PDF was aspirated and creatinine, urea and sodium were measured. The quotient of dialysate and plasma was determined and the transport type was estimated according to [34, 35] .
Determination of dicarbonyl content in PDF
The concentration of 3-DG, MG and Gx in PDF was determined by derivatization with 1,2-diamino-4,5-dimethoxybenzene, as previously described [36] .
Preparation of total protein extract Frozen peritoneal tissue was grounded to a fine powder using liquid nitrogen. The homogenate was resuspended in ice-cold lysis buffer (10 mM HEPES, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 0.6% NP40, 0.5 mM DTT, 0.2 mM PMSF; pH 7.9) and incubated on ice for 20 min. The tissue homogenates were then vortex and centrifuged (15000 g, 10 min, 4°C), and supernatants were retained for analysis. The protein concentration for cell and tissue homogenates was determined by Bradford assay using BSA as a standard [37] .
Assay of Glo1 activity Glo1 activity was determined by using the spectrometric method, which monitors the initial rate of change in absorbance at 240 nm caused by the formation of S-d-lactoylglutathione [38] . For the conversion of the hemithioacetal to S-d-lactoylglutathione, the change in molar extinction coefficient was Δε 240 = 2.86/mM/cm. The standard assay mixture contained 2 mM MG and 2 mM GSH in sodium phosphate buffer (50 mM, pH 6.6, 37°C). The reaction mixture was allowed to stand for 10 min before the addition of the cytosolic protein fraction (20 µg) to ensure the equilibrium of hemithioacetal formation. The activity of Glo1 is given in units (U), where 1 U is the amount of Glo1 that catalyses the formation of 1 µmol of S-dlactoylglutathione per minute under the stated assay conditions.
Quantitative real-time PCR Total RNA was isolated from pulverized peritoneal tissue using the GeneElute™ Mammalian Total RNA miniprep kit (Sigma-Aldrich Chemie, Taufkirchen, Germany), according to the manufacturer's instructions. One microgram of RNA was reverse transcribed (High Capacity cDNA Transcription kit, Applied Biosystems, Inc., Foster City, CA, USA) and transcripts quantified using a Roche LightCycler 480 (Roche Diagnostics, Mannheim, Germany) and KAPA SYBER Fast Master Mix (PEQLAB Biotechnologie GmbH, Erlangen, Germany), according the manufacturer's instructions. The following primer pairs were used: Glo1: 5 0 -GATTTGGTCACATTGG GATTGC-3 0 and 5 0 -TCCTTTCATTTTCCCGTCATCAG-3; RAGE: 5 0 -CTTGCTCTATGGGGAGCTGTA-3 0 and 5 0 -GGA GGATTTGAGCCACGCT-3 0 ; β-actin (Reference gene): 5 0 -GG CTGTATTCCCCTCCATCG-3 0 and 5 0 -CCAGTTGGTAAC AATGCCATGT-3 0 . Melting curve profiles were used to confirm amplification of specific transcripts, and the level of expression was calculated from the respective ΔCt value, based on the second derivative maximum method.
Serum total protein fluorescence Total protein fluorescence relating to oxidative and glycation fluorescence of serum samples was performed using a spectrofluorometer (LS 50 B, Perkin Elmer, Überlingen, Germany). For measuring fluorescence, intensity excitation wavelength was set at 350 nm and emission wavelength at 430 nm. Samples were diluted accordingly.
Statistical analysis
All values are expressed as mean ± SEM. Kruskal-Wallis and Mann-Whitney tests were used as appropriate to test statistical significance. Significance level was set at P < 0.05. Statistical analysis was performed by PC-Statistik (version 5.0, Hoffmann, Giessen, Germany) and GraphPad Prism (version 5; La Jolla, CA, USA).
R E S U LT S
Baseline characteristics
In comparison with WT mice, Glo1 −/+ animals revealed a significantly higher peritoneal expression and activity of Figure 1) . Table 2 and Figure 1 .
Dicarbonyl content
Peritoneal MG, Gx AGE and RAGE-formation In WT mice treated with PDF, there was only a minor increase within the peritoneal membrane of MG-AGE and CML, a major AGE formed from lysine and Gx when compared with untreated animals (Figure 2 ). However, a more pronounced increase in MG-AGE was observed in Glo1 −/+ mice treated with high GDP-PDF in comparison to low-GDP treatment ( peritoneal staining for MG-AGE: Glo1 −/+ + low GDP 3.94 ± 0.29 versus Glo1 −/+ + high GDP 6.16 ± 0.48; P < 0.001). The accumulation of CML was significantly higher in Glo1 treated with high GDP-PDF ( peritoneal staining for RAGE: Glo1 −/+ + low GDP 5.39 ± 0.36 versus Glo1 −/+ + high GDP 8.27 ± 0.50; P < 0.01).
Serum protein fluorescence
The serum protein fluorescence was increased in Glo1 −/+ animals treated with high GDP-PDF compared with control: Glo1 −/+ C 3139 ± 203 versus Glo1 −/+ + high GDP 4807 ± 714; P < 0.05 (Supplementary Table 1 ).
Peritoneal inflammation
There was a GDP-dependent increase in IL-6 expression in mice treated with PDF. Glo1 −/+ mice treated with high GDP were found to have the highest level of IL-6 expression (IL-6 expression: WT + high GDP 6.91 ± 0.28 versus Glo1 −/+ + high GDP 8.83 ± 0.27; P < 0.001; Figure 3 ).
Peritoneal neovascularization WT mice treated with PDF had a dose-dependent increase of peritoneal VEGF score and vessels per area ( Figure 3B and C). Untreated Glo1 −/+ mice had a comparable VEGF score and number of vessels when compared with untreated WT mice. Treatment with PDF, in particular high GDP-PDF, led to a significant increase in vessels per area and VEGF staining (VEGF expression: WT + high GDP 6.91 ± 0.28 versus Glo1 −/+ + high GDP 8.83 ± 0.27; P < 0.001; Figure 3 ).
Peritoneal fibrosis and epithelial-mesenchymal transition WT mice treated with low GDP-PDF showed an increased submesothelial thickness when compared with WT sham: WT mice treated with high GDP-PDF showed an increase in thickness compared with WT mice treated with low 
O R I G I N A L A R T I C L E
G l y o x a l a s e 1 i n p e r i t o n e a l d i a l y s i s GDP-PDF. A similar effect was also observed in Glo1 −/+ mice. In comparison with WT mice, the submesothelial thickness of Glo1 −/+ mice was markedly increased. A dose-dependent increase in TGF-β1 was also observed in the PD-treated mice, with the highest level of positive staining being observed in Glo1 −/+ mice treated with high GDP-PDF (TGF-β1 expression: WT + high GDP 3.21 ± 0.27 versus Glo1 −/+ + high GDP 5.52 ± 0.42; P < 0.001; Figure 4) . Staining for vimentin, a marker of epithelial-mesenchymal transition, showed an increased level of staining in the Glo1 −/+ mice treated with high GDP in comparison to controls (Figure 4) .
Peritoneal function PET analysis indicated that the Glo1
−/+ high GDP-PDF revealed a faster transport type compared with control (D/P urea : Glo1 −/+ C 0.58 ± 0.05 versus Glo1 −/+ + high GDP 0.87 ± 0.04; P < 0.01; Table 3 ).
D I S C U S S I O N
In this study, it has been shown that mice deficient in Glo1, an enzyme that is part of the glyoxalase system and the major route for the detoxification of the dicarbonyls MG and Gx, are more susceptible to PDF-induced peritoneal damage when compared with WT mice. Treatment with PDF for 3 months showed that Glo1 −/+ mice had increased loss of peritoneal function and increased fibrosis, inflammation and angiogenesis, which was dependent upon the GDP load of the PDF used. These data suggest that within the context of PD, the level of Glo1 activity provides a previously unrecognized protective mechanism against the failure of long-term PD.
It has previously been shown that there is a time-dependent association between GDP and the accumulation of AGE in the peritoneal membrane of patients undergoing PD [17, 18] , which is supported, in part, by the findings of this study. It was shown that there was increased accumulation of both MG-and Gx-derived AGE within the peritoneal membrane as the content of GDPs in the PDF increased. This would suggest that the on-going peritoneal damage observed in patients undergoing PD is in part caused by the highly toxic nature of GDP. However, it is imperative to establish which component of GDP is responsible for the biological effects observed.
The concentration of dicarbonyls in PDF has been reported [39] . It has been shown that the concentration of 3-DG, Gx −/+ mice treated with high GDP containing PDF for 12 weeks. Representative images of vimentin staining are given in C (right panel). Magnification ×600, scale bar represents 33 μm. TGF-β1, transforming growth factor-β1; Glo1 −/+ , Glyoxalase 1-deficient; GDP, glucose degradation products; PDF, peritoneal dialysis fluid. **P < 0.01 versus low GDP of the respective group; *P < 0.05 versus low GDP of the respective group; and MG found in PDF are within a micro-molar range (1-200 µM), with the levels of the 3-DG being ∼100-fold higher than either Gx or MG [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . It is not surprising to find that the concentration of 3-DG is higher; based upon the non-enzymatic fragmentation of glucose, with the order of dicarbonyl production from glucose is Gx > 3-DG > MG [37] . However, with respect to potency, 3-DG is a poor posttranslational modifier of proteins. In contrast, while the concentration of MG and Gx in PDF is low, their potency to react with proteins is significantly higher, suggesting that these dicarbonyls are key mediators of the peritoneal damage observed with PDF. This is supported, in part, by the central finding of this study that the loss of Glo1 leads to increased peritoneal damage in response to PDF, as both MG and Gx are the major substrates for Glo1, whereas 3-DG is not [24] . It is interesting to note that the level of CML, a major adduct of Gx, within the peritoneal membrane was significantly higher than the MGderived AGE. This would suggest that the concentration of Gx within the PDF was higher than MG, which is consistent with our data and previous estimates [39] . However, as Gx is also generated from lipid peroxidation, it may also be suggestive of increased oxidative stress. It has been reported that a primary target of protein modification by MG is the mitochondria [27] , leading increased production of ROS and potentially increased lipid peroxidation. This secondary mechanism resulting from increased exposure to MG could also be active within the peritoneal membrane, leading to further modification and damage by Gx.
Additional experiments are required to further define the association between increased post-translational modification by dicarbonyls and observed activation and increase in inflammation. In this regard, it is interesting to note that the expression of the RAGE was increased in WT and Glo1 −/+ mice following treatment with PDF. This cell-surface receptor has previously been shown to interact and bind to AGE-modified proteins, leading to an enhanced inflammatory response [15, 40] . Other RAGE ligands have been described subsequently, including RAGE to possess a multi-ligand nature and have been termed a 'pattern recognition' receptor due to the diverse variety of the ligands that bind and transmit cellular signalling through RAGE. These ligands, in addition to AGEs, include members of the s100/calgranulin family, HMGB1 (high-mobility group box-1), amyloid fibrils and the counter-receptor for β-integrins, Mac-1. Although the levels of these ligands were not determined in this study, activation of RAGE is associated with decreased expression of Glo1; induction of diabetes in WT mice decreased expression of Glo1 whereas induction of diabetes in RAGE −/− mice did not [40] . The molecular mechanism which underlies this association has yet to be fully understood. Nevertheless, studies involving the blocking of RAGE provide that RAGE is also an important factor in GDPinduced peritoneal damage [15, 41] .
In recent years, many approaches have been introduced to lower peritoneal toxicity of PDF. Blocking growth factors, such as TGF-β1 [42] , and the administration of anti-fibrotic drugs, such as rosiglitazone [43] , have been reported to be successful in this regard. However, less attention has been given to the potential modulation of a patient's native detoxifying systems.
It has been shown that the peritoneal membrane can be protected against PDF-induced damage by high glucose by treatment with benfotiamine, an analogy of thiamine and cofactor for transketolase [20] . Increased transketolase activity, in vitro and in vivo, has been shown to prevent the accumulation of MG by activation of the pentose-phosphate pathway, which shifts glycolytic flux away from the accumulation of triose phosphates (glyceraldeyhde-3-phosphate and dihydroxyacetone phosphate), the precursors of MG, into the formation of ribose-5-phosphate [44] [45] [46] . The use of benfotiamine may therefore be an effective therapeutic option in PD; however, its usefulness would be limited in the context of PD by only addressing the direct effect of high glucose from PDF and not the effect of the GDPs MG and Gx.
A more direct approach could include the administration of GSH, a scavenger of dicarbonyls and cofactor for the glyoxalase system. It has been shown, in vitro, that supplementation of PDF with GSH can reduce the content of dicarbonyls [31] . Furthermore, it has been reported that PD patients are deficient in GSH [47, 48] . Thus, administration of GSH, in particular esterified GSH which is more cell permeable, may help boost a patient's native Glo1 activity by providing an excess of the cofactor. As GSH is also a potent antioxidant, it would also provide a means of reducing an oxidative stress that may also be generated from the PDF.
A more effective scavenger of dicarbonyls is aminoguandine, which has been shown in vitro to be more effective than GSH in reducing the content of dicarbonyls in PDF [31, 49] . Aminoguanidine is also an inhibitor of ROS formation by divalent metal chelation [50] , and this appears to be more important than scavenging of dicarbonyls in the observed effects [51] . However, aminoguanidine could only be used prior to administration of a PDF to a patient, as studies have shown that it has significant side-effects at clinically relevant concentrations [52] .
Nevertheless, the findings of this study identify for the first time in vivo a pivotal role for Glo1 as a detoxifying enzyme in GDP-associated peritoneal toxicity in PD. The indirect and direct modulation of Glo1 may therefore offer a new , Glyoxalase 1-deficient; C, control; IP, intraperitoneal injection; GDP, glucose degradation products; PDF, peritoneal dialysis fluid; D, dialysate; P, plasma. 
O R I G I N A L A R T I C L E
G l y o x a l a s e 1 i n p e r i t o n e a l d i a l y s i s therapeutic option in prevention of GDP-induced peritoneal damage in PD.
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